You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 419 Pharmacodynamic biomarkers demonstrate T-cell activation in patients treated with the oral PD-L1 inhibitor INCB086550 in a phase 1 clinical trial

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
419 Pharmacodynamic biomarkers demonstrate T-cell activation in patients treated with the oral PD-L1 inhibitor INCB086550 in a phase 1 clinical trial

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020305081
Dec 202096066
Jan 202192025
Feb 202188032
Mar 202172021
Apr 2021114034
May 202168045
Jun 20211032
Jul 20210030
Aug 20210031
Sep 20210025
Oct 202192036
Nov 2021173056
Dec 202186018
Jan 202266012
Feb 202252019
Mar 202292019
Apr 202286017
May 202286016
Jun 2022138019
Jul 2022108012
Aug 202296018
Sep 202298013
Oct 20227203
Nov 20229202
Dec 2022130015
Jan 202364010
Feb 202348010
Mar 202362010
Apr 202356012
May 202356019
Jun 20234605
Jul 202366010
Aug 20236609
Sep 20236805
Oct 202313204
Nov 202324807
Dec 2023110014
Jan 20246204
Feb 20249207
Mar 20245205
Apr 20248006
May 20246806
Jun 20246408
Jul 20243202
Aug 20243009
Sep 20244406
Oct 202460012
Nov 202474012
Dec 202472013
Jan 202546016
Feb 20251406
Mar 2025006
Apr 2025005
May 2025005
Jun 2025006
Total41150946